UNICYCIVE THERAPEUTICS, INC. Restricted Investments, at Fair Value
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Restricted Investments, at Fair Value of $11.78 thousand as of 2025-07-01, per its 10-Q filed 2026-05-12.
Financial Statements › Notes
us-gaap:RestrictedInvestmentsAtFairValue · last filed 2026-05-12
- 2025-07-01: Restricted Investments, at Fair Value $11.78K.
- 2024-08-31: Restricted Investments, at Fair Value $4.00K.
- 2023-08-31: Restricted Investments, at Fair Value $7.50K; Restricted Investments, at Fair Value as first filed $7.50M.
- 2022-05-31: Restricted Investments, at Fair Value $7.20K.
| Period end | Restricted Investments, at Fair Value | Restricted Investments, at Fair Value as first filed |
|---|---|---|
| 2025-07-01 | $11.78K 10-Q · filed 2026-05-12 | |
| 2024-08-31 | $4.00K 10-Q · filed 2026-05-12 | |
| 2023-08-31 | $7.50K 10-Q · filed 2026-05-12 | $7.50M 10-Q · filed 2023-11-14 |
| 2022-05-31 | $7.20K 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |